What to know first
- Apomorphine has clinical research, but those studies did not test Ready’s three-drug formulation.
- Membership pages describe 30- and 90-day plans with shipping and consultation-fee benefits.
- The terms specify 72-hour cancellation notice; support pages also describe 24-hour order changes.
These product reviews examine public formulation information, research, and service terms. We have not ordered the treatments, tested their effects, or audited patient care. How we research.
What Ready contains
Rugiet’s ingredient article identifies three active ingredients in Ready: sildenafil, tadalafil, and apomorphine. The product is a compounded troche that dissolves under the tongue. The current product page also lists those three ingredients and says a prescription requires a clinician’s assessment.
Rugiet markets the combination in terms of blood flow and arousal. That is the provider’s explanation of the product, not a finding that this formula treats every cause of ED. Symptoms may involve health conditions, medicines, stress, or relationship factors. Ask what assessment is needed for your situation before deciding that a combination is the next step.
Ready, a troche, and a standard tablet are different things
A troche is a medication format intended to dissolve in the mouth; Ready is marketed for sublingual use. The format does not establish which ingredients or strengths another troche contains. Similarly, a product sharing sildenafil or tadalafil with Ready is not necessarily the same treatment.
Ask for the final prescription’s complete formula and the pharmacy’s administration and storage instructions. The product page notes that actual supplied products may differ from the image and are filled through partner pharmacies. The label on your own medication is therefore more important than matching a photograph.
For a fixed three-ingredient product, ask how a prescriber would adjust treatment if one component appears to cause a problem. A greater number of ingredients is not a measure of how advanced your ED is, and does not by itself identify the right next step after a single-ingredient medicine disappoints.
Our guide to compounded formats explains why route, formulation, and evidence need to be considered separately. Do not convert another product’s instructions into a Ready dose.
The price detail still needed before ordering
The provider’s ingredient article included a starting figure of $7.29 per dose when checked October 7, 2026. The public product page we reviewed did not establish the corresponding quantity, full charge, billing interval, or renewal terms. That starting figure is therefore a prompt to check a quote, not a verified all-in price.
Do not compare that figure directly with four doses on another service’s monthly plan without identifying the matching quantity and commitment. Ask whether the quoted amount includes the clinical assessment, medication, shipping, and any follow-up. Confirm how many prescribed uses a shipment actually represents.
Our cost guide walks through the billing questions. We have not completed checkout or audited Rugiet’s refund and cancellation handling.
What membership includes—and what remains unverified
Rugiet’s membership help page describes 30-day and 90-day subscriptions. It says both include free shipping and a waived annual doctor consultation fee, while the 90-day option includes an additional medication discount. These are stated membership benefits, not proof that the same fees apply to every non-member order.
The public material reviewed still did not supply a complete price grid tying the $7.29 starting figure to quantity, strength, payment interval, and renewal total. We therefore do not multiply that figure into a supposed monthly bill or compare it as an equivalent to Ro’s four-dose plan.
Before choosing a larger shipment, ask what happens if the prescriber changes the formula early. A lower unit price can be less useful if medication remains unused and the order cannot be refunded. Also ask whether a discount changes on renewal and whether any consultation charge returns when membership ends.
Keep a copy of the selected quote. Record the medication cost, any service fee, delivery charge, taxes, and next billing date separately. This makes the total understandable even when an offer emphasizes only the per-dose amount.
Consultation, dispensing, and follow-up
Rugiet describes a health questionnaire, review by a licensed U.S. physician, and discreet delivery if treatment is prescribed. The Ready page lists partner fulfillment pharmacies. Ask for the dispensing pharmacy’s name and contact information, plus the correct channel for questions about your prescription.
We have not tested delivery speed or customer support. Before buying, clarify what happens if the clinician recommends another option, whether an order can be changed before fulfillment, and how you can obtain follow-up care. A marketing delivery estimate is not a commitment for every address or prescription.
A closer look at the cancellation and refund language
The terms and conditions require a cancellation request at least 72 hours before the billing date to avoid another charge. The membership help page and refund support article also describe making changes at least 24 hours before an order is processed. These use different deadlines and different reference events: billing versus processing.
Do not assume the shorter window overrides the subscription terms. Ask support which rules apply to your selected plan, act before the earlier relevant deadline, and retain the confirmation. This review reports the published language; it does not determine how a particular billing dispute would be resolved.
The cancellation guide provides an account route through the prescription’s plan controls and says an in-progress order cannot be canceled once medication has been processed. The terms tie ordinary refund eligibility to whether medication has already been ordered, while the support article excludes dissatisfaction based on flavor, side effects, or lack of efficacy.
Damaged or incorrect items are addressed separately and may be considered for replacement or a refund. Report an issue promptly through support rather than returning medication without authorization. A product not meeting your expectations, a dispensing error, and a clinical decision that you are unsuitable for treatment are different situations under the published policies.
How to read the performance claims
The Ready product page promotes faster onset and longer-lasting effects. One footnote attributes its average onset comparison to an internal customer survey after the medicine dissolves. A reported average from a customer survey is not a guaranteed onset time or a randomized comparison of the exact products you are considering.
Ready is compounded and not FDA-approved. FDA’s explanation of compounding is useful when separating evidence for individual ingredients from evidence for a finished combination. More ingredients do not establish a more appropriate treatment for your health history.
Because Ready includes sildenafil and tadalafil, ask about overlapping effects and interactions. Standard tadalafil prescribing information advises against combinations with other PDE5 inhibitors. Do not add another ED treatment yourself. Your clinician should explain the rationale and whether an approved single-ingredient medicine could meet your needs.
What the apomorphine studies add to this review
A 2001 randomized crossover study enrolled 296 men across two comparisons of sublingual apomorphine. It found a benefit over placebo and more adverse events with the higher studied dose; nausea was a notable adverse effect. That is evidence about specific single-ingredient formulations, not the Ready mixture.
A later crossover comparison with sildenafil had only 34 evaluable participants despite a larger enrollment. Sildenafil performed better on the reported erection and intercourse outcomes. The small evaluable sample and attrition limit generalization, and the study did not test adding apomorphine to sildenafil and tadalafil.
Taken together, these studies give a more useful account than either “apomorphine has no research” or “its mechanism proves a superior combination.” They show a drug with a research history and limitations. The additional question is whether the exact combination, strengths, route, and schedule improve outcomes for the person being treated.
We reviewed the indexed abstracts via NCBI and did not obtain a full independent appraisal of all trial methods. We did not verify a randomized trial of the finished Ready formulation in this source review. Rugiet’s customer survey claims should therefore be read as a different type of evidence, with different strengths and limitations.
Ask the clinician what they expect the extra ingredient to contribute, how they would monitor tolerability, and what they would do if a simpler treatment is appropriate. An explanation of brain signaling can be informative, but it is not a substitute for that clinical discussion.
The closest comparisons
Ro Sparks versus Rugiet Ready focuses on the difference between a two-ingredient and three-ingredient sublingual product. BlueChew GOLD lists a different four-ingredient combination, while CoreAge Rx 4Play uses a different liquid formula. These products are not interchangeable prescriptions.
- What does adding apomorphine aim to address in my case?
- What evidence supports this exact formulation for me?
- How will we monitor response and side effects?
- What is the full price and the renewal commitment?
Frequently asked questions
Does Ready contain the same ingredients as Ro Sparks?
Both list sildenafil and tadalafil. Ready also lists apomorphine. That additional ingredient makes the finished formulation different; it does not establish better results for every patient.
Is the $7.29 figure a verified monthly price?
No. It is a provider-published starting figure per dose. The reviewed public sources did not establish a complete matching plan total and billing commitment.
Should I use the 24-hour or 72-hour cancellation window?
The terms say 72 hours before billing; support pages also discuss 24 hours before processing for changes. Ask which applies to your plan and act early enough for both, rather than relying on the shorter window.
Does membership make medication refundable if it does not work?
The reviewed support policy excludes refunds for lack of efficacy, side effects, or flavor dissatisfaction. Clinical follow-up remains important, but membership should not be read as a general response guarantee.
Does a 15-minute claim mean I should take more if nothing happens then?
No. The provider’s timing claims are averages or marketing descriptions, not a redosing instruction. Follow your own prescription and contact the clinician if response is inadequate.
Compare formulas, formats, and full costs.
Use the exact product and prescription to prepare a conversation with your clinician.
Compare ED productsSources & notes
Sources checked October 7, 2026. Provider pages establish what is advertised, not independently verified clinical outcomes.
- Rugiet: Ready product information
Provider source; current compounded product and consultation process - Rugiet: Ready ingredients explained
Provider source; sildenafil, tadalafil, and apomorphine formulation - FDA: Compounding and the FDA — questions and answers
Government guidance on compounded medications - DailyMed: Tadalafil prescribing information, including section 5.11
Prescribing label; not evidence for the 4Play combination - FDA: Locate a state-licensed online pharmacy
Government pharmacy verification resource - Rugiet Support: membership options and inclusions
Provider support; plan intervals, shipping, and consultation fees - Rugiet: terms and conditions
Provider policy; 72-hour subscription cancellation notice and refund eligibility - Rugiet Support: canceling an order or subscription
Provider support; member portal steps and processing restrictions - Rugiet Support: treatment response and refunds
Provider policy; refund exclusions and 24-hour order-change notice - Dula et al. (2001): sublingual apomorphine crossover trial
Primary randomized trial; single-ingredient apomorphine, abstract reviewed via NCBI - Pavone et al. (2004): apomorphine versus sildenafil
Primary crossover study; 34 evaluable participants, abstract reviewed via NCBI - Cui et al. (2015): daily tadalafil with as-needed sildenafil
Primary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI